Target intelligence / Profile preview

Positively charged extracellular proteins

Molecular classification
Other
01

Overview

Positively charged extracellular proteins represent a functional class of proteins characterized by high isoelectric points, enabling them to interact electrostatically with negatively charged components of the extracellular environment, such as glycosaminoglycans (GAGs), heparan sulfate, and extracellular DNA (eDNA). This group encompasses a wide range of molecules, including growth factors (e.g., FGF, VEGF), chemokines, degradative enzymes (e.g., elastase, hyaluronidase), and cytotoxic proteins released during cell death, most notably extracellular histones. In physiological conditions, these proteins are essential for organizing the extracellular matrix (ECM) and regulating signaling gradients. However, their dysregulated release or overabundance is a hallmark of various diseases, including sepsis, where extracellular histones act as major mediators of systemic inflammation and organ failure. Therapeutic targeting of this class typically involves the use of polyanionic drugs like pentosan polysulfate sodium or non-anticoagulant heparinoids (e.g., STC3141), which bind and neutralize these cationic proteins to prevent their pro-inflammatory and tissue-damaging effects.

Other names
Cationic extracellular proteinsCationic proteinsBasic extracellular proteinsHeparin-binding proteins
02

Mechanism of action

Electrostatic binding and neutralization of cationic proteins to inhibit pro-inflammatory signaling, sequester growth factors, and prevent enzymatic degradation of the extracellular matrix.

03

Biological functions

Extracellular matrix organizationSignal transductionImmune responseCell adhesionBlood coagulationBiofilm stabilization
04

Disease associations

InflammationSepsisCancerOsteoarthritisInterstitial cystitisInfectionAcute respiratory distress syndrome (ARDS)
05

Safety considerations

Off-target binding to essential cationic proteinsAnticoagulant effects (for heparin-based drugs)Interference with normal extracellular matrix signalingHypersensitivity reactions
06

Interacting drugs

Pentosan polysulfate sodium

4 more in the full profile.

07

Biomarkers

Extracellular histone levelsEosinophil cationic protein (ECP)Major basic protein (MBP)Neutrophil elastase

Beyond the preview

Go deeper on Positively charged extracellular proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Positively charged extracellular proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call